BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 19428047)

  • 21. Inhibition of 4E-BP1 sensitizes U87 glioblastoma xenograft tumors to irradiation by decreasing hypoxia tolerance.
    Dubois L; Magagnin MG; Cleven AH; Weppler SA; Grenacher B; Landuyt W; Lieuwes N; Lambin P; Gorr TA; Koritzinsky M; Wouters BG
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1219-27. PubMed ID: 19251093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.
    Salehi Z; Mashayekhi F
    Clin Biochem; 2006 Apr; 39(4):404-9. PubMed ID: 16375881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
    González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
    Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of mTOR in a subgroup of ovarian carcinomas: correlation with p-eIF-4E and prognosis.
    Noske A; Lindenberg JL; Darb-Esfahani S; Weichert W; Buckendahl AC; Röske A; Sehouli J; Dietel M; Denkert C
    Oncol Rep; 2008 Dec; 20(6):1409-17. PubMed ID: 19020722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 is correlated with low BMI negative progesterone receptor status and recurring disease in patients with endometrial cancer.
    Seeger A; Kölbl H; Petry IB; Gebhard S; Battista MJ; Böhm D; Steiner E
    Gynecol Oncol; 2012 Apr; 125(1):200-7. PubMed ID: 22210468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C; Wejaranayang C; Vipupinyo C
    J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.
    Williams MD; Roberts D; Blumenschein GR; Temam S; Kies MS; Rosenthal DI; Weber RS; El-Naggar AK
    Am J Surg Pathol; 2007 Nov; 31(11):1645-52. PubMed ID: 18059220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
    Cuatrecasas M; Catasus L; Palacios J; Prat J
    Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BCL-2 and P53 expression in endometrial carcinoma.
    Erkanli S; Eren F; Pekin S; Bagis T
    J Exp Clin Cancer Res; 2004 Mar; 23(1):97-103. PubMed ID: 15149157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.
    Velasco A; Pallares J; Santacana M; Gatius S; Fernandez M; Domingo M; Valls J; Yeramian A; Encinas M; Dolcet X; Matias-Guiu X
    Hum Pathol; 2011 Feb; 42(2):185-93. PubMed ID: 21111454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of neuroendocrine expression in undifferentiated carcinoma of the endometrium.
    Taraif SH; Deavers MT; Malpica A; Silva EG
    Int J Gynecol Pathol; 2009 Mar; 28(2):142-7. PubMed ID: 19188820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas.
    Allard JE; Risinger JI; Morrison C; Young G; Rose GS; Fowler J; Berchuck A; Maxwell GL
    Gynecol Oncol; 2007 Oct; 107(1):52-7. PubMed ID: 17582475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray.
    Dupont J; Wang X; Marshall DS; Leitao M; Hedvat CV; Hummer A; Thaler H; O'Reilly RJ; Soslow RA
    Gynecol Oncol; 2004 Aug; 94(2):449-55. PubMed ID: 15297187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of translation factors eIF4GI and 4E-BP1 during recovery of protein synthesis from inhibition by p53.
    Constantinou C; Clemens MJ
    Cell Death Differ; 2007 Mar; 14(3):576-85. PubMed ID: 16990847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenethyl isothiocyanate, a cancer chemopreventive constituent of cruciferous vegetables, inhibits cap-dependent translation by regulating the level and phosphorylation of 4E-BP1.
    Hu J; Straub J; Xiao D; Singh SV; Yang HS; Sonenberg N; Vatsyayan J
    Cancer Res; 2007 Apr; 67(8):3569-73. PubMed ID: 17440067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential ErbB receptor expression and intracellular signaling activity in lung adenocarcinomas and squamous cell carcinomas.
    López-Malpartida AV; Ludeña MD; Varela G; García Pichel J
    Lung Cancer; 2009 Jul; 65(1):25-33. PubMed ID: 19046792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of NLRP7 (PYPAF3, NALP7) protein in endometrial cancer tissues.
    Ohno S; Kinoshita T; Ohno Y; Minamoto T; Suzuki N; Inoue M; Suda T
    Anticancer Res; 2008; 28(4C):2493-7. PubMed ID: 18751440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lactoferrin immunoexpression in endometrial carcinomas: relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival.
    Giuffrè G; Arena F; Scarfì R; Simone A; Todaro P; Tuccari G
    Oncol Rep; 2006 Aug; 16(2):257-63. PubMed ID: 16820900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of phosphorylated 4E-binding protein 1 and its clinicopathological significances in gastric cancer.
    Lee HW; Park MI; Kim MS; Kim SH; Roh MS; Kim K; Jung SB; Lee EH
    Pathol Res Pract; 2015 Apr; 211(4):298-302. PubMed ID: 25661069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome.
    Chatterjee D; Sabo E; Tavares R; Resnick MB
    Clin Cancer Res; 2008 May; 14(10):2994-3001. PubMed ID: 18483365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.